abstract |
The present invention provides the use of molecules for models of cholinergic and / or serotoninergic systems, 11-OH-erythrabin, erythrabin, erythrartine, pharmaceutically acceptable isotopes, salts, by-products and / or Or a pharmaceutical composition for treating anxiety disorders, including solvates and optionally other erythrina by-products. A method for obtaining the pharmaceutical composition is also clarified. |